Northern Trust Corp Avenue Therapeutics, Inc. Transaction History

Northern Trust Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$2.41 - $7.11 $152,509 - $449,935	-63,282 Reduced 82.13%	13,767 $35,000
Q1 2021 May 12, 2021	SELL	$4.7 - $7.17 $26,517 - $40,453	-5,642 Reduced 6.82%	77,049 $467,000
Q4 2020 Feb 11, 2021	BUY	$2.95 - $11.04 $5,091 - $19,055	1,726 Added 2.13%	82,691 $492,000
Q3 2020 Nov 16, 2020	BUY	$9.37 - $12.06 $468,275 - $602,710	49,976 Added 161.27%	80,965 $877,000
Q2 2020 Aug 14, 2020	BUY	$8.29 - $11.47 $136,130 - $188,348	16,421 Added 112.72%	30,989 $334,000
Q4 2018 Feb 12, 2019	BUY	$2.1 - $5.6 $30,592 - $81,580	14,568 New	14,568 $79,000

Ticker ATXI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 4,127,720
Market Cap $9.25M
Description
Avenue Therapeutics, Inc., a specialty pharmaceutical company, develops and commercializes products primarily for use in the acute/intensive care hospital setting. Its product candidate is intravenous Tramadol, a synthetic dual-acting opioid, which is in Phase III clinical trials for the treatment of post-operative acute pain. The company was in...

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

Stay updated on Northern Trust Corp with notifications on news.